Most sinus infections don’t require antibiotics
To ease symptoms of a sinus infection, Dr. File said he recommends patients take acetaminophen for sinus pain, use saline irrigation and drink plenty of fluids.
The voluntary guidelines are not intended to take the place of a doctor’s judgment, but rather support the decision-making process, which must be individualized according to each patient’s circumstances.
EPIDEMIOLOGY: Sinusitis affects more than 30 million adults in the United States annually.
Direct costs of sinusitis in the US, resulting from medications, outpatient and emergency room visits, and ancillary tests and procedures, are estimated at $3 billion per year. The socioeconomic impact is further magnified by indirect costs from decreased productivity, days lost from work, and impaired quality of life.
PATHOPHYSIOLOGY — The vast majority of cases of acute rhinosinusitis (ARS) are due to viral infection. As noted above, acute bacterial infection occurs in only 0.5 to 2.0 percent of episodes. The most common viruses, determined by maxillary sinus puncture and aspiration, are rhinovirus, influenza virus, and parainfluenza virus.
Acute viral rhinosinusitis (AVRS) begins with viral inoculation via direct contact with conjunctiva or nasal mucosa. Viral replication in a nonimmune individual leads to detectable viral levels in nasal secretions within 8 to 10 hours. Symptoms, if they develop, usually present in the first day after inoculation.
Viral rhinitis spreads to the paranasal sinuses by systemic or direct routes. Nose blowing may be an important mechanism; positive intranasal pressures generated during nose blowing may propel contaminated fluid from the nasal cavity into the paranasal sinuses. Inflammation follows, resulting in sinonasal hypersecretion and increased vascular permeability, followed by transudation of fluid into the nasal cavity and sinuses. Viruses also can exert a direct toxic effect on nasal cilia, impairing mucociliary clearance. A combination of mucosal edema, copious thickened secretions, and ciliary dyskinesia results in sinus obstruction and perpetuates the disease process.
Community-acquired acute bacterial rhinosinusitis (ABRS) occurs when bacteria secondarily infect the inflamed sinus cavity. Although usually occurring as a complication of viral infection, other predisposing conditions associated with acute bacterial sinusitis include allergy, mechanical obstruction of the nose, swimming, odontogenic infection, intranasal cocaine use, impaired mucociliary clearance (eg, cystic fibrosis, cilial dysfunction), immunodeficiency, and other factors that impair sinus drainage.
###
The 11-member guidelines panel comprises rhinosinusitis experts representing a variety of organizations, including the Centers for Disease Control and Prevention (CDC), the American College of Physicians, and the Society of Academic Medicine. In addition to Drs. Chow and File, the rhinosinusitis guidelines panel includes: Michael S. Benninger, Itzhak Brook, Jan L. Brozek, Ellie J.C. Goldstein, Lauri A. Hicks, George A. Pankey, Mitchel Seleznick, Gregory Volturo, and Ellen R. Wald.
IDSA has published more than 50 treatment guidelines on various conditions and infections, ranging from HIV/AIDS to Clostridium difficile. As with other IDSA guidelines, the rhinosinusitis guidelines will be available in a format designed for iPhones and other mobile devices, and in a pocket-sized quick-reference edition. Note: For a copy of the rhinosinusitis guidelines, to be published in the April 15 issue of Clinical Infectious Diseases, please contact Ashley Mattys at (312) 558-1770 or .(JavaScript must be enabled to view this email address). The guidelines are embargoed until 12:01 a.m. EDT on March 21, 2012.
Founded in 1979, Clinical Infectious Diseases publishes clinical articles twice monthly in a variety of areas of infectious disease, and is one of the most highly regarded journals in this specialty.
The Infectious Diseases Society of America (IDSA) is an organization of physicians, scientists, and other health care professionals dedicated to promoting health through excellence in infectious diseases research, education, patient care, prevention, and public health. The Society, which has nearly 10,000 members, was founded in 1963 and is based in Arlington, Va.
###
Ashley Mattys
.(JavaScript must be enabled to view this email address)
312-558-1770
Infectious Diseases Society of America